Lisa Ward
Family Medicine · Elkton, MDNPI 1740752971
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 1,187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 8.1% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,187 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$2K
- GSK$2K
- Amgen$1K
- Novo Nordisk$1K
- Pfizer$1K
- plus $14K from 54 others
What the payments were for
- Food & beverage$22,58499%
- Education$1911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,774 in reported general payments places this provider in the 95th percentile of 1,193 family medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 34 | $47,520 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 55 | $41,128 |
| EliquisApixaban | 43 | $37,830 |
| OzempicSemaglutide | 31 | $32,771 |
| FarxigaDapagliflozin Propanediol | 34 | $27,339 |
| LinzessLinaclotide | 26 | $26,312 |
| MounjaroTirzepatide | 19 | $21,705 |
| JardianceEmpagliflozin | 27 | $20,592 |
| MyrbetriqMirabegron | 18 | $17,076 |
| Breo ElliptaFluticasone/Vilanterol | 31 | $16,506 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $14,191 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 30 | $12,668 |
| XareltoRivaroxaban | 14 | $11,841 |
| Repatha SureclickEvolocumab | 12 | $10,548 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $10,412 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $1,217 | $69,22553 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $1,545 | $64,059100 claims |
| PfizerEliquis | $1,260 | $37,83043 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,754 | $37,75249 claims |
| Novo NordiskOzempic | $1,273 | $32,77131 claims |
| AbbVieLinzess | $1,835 | $26,31226 claims |
| Boehringer IngelheimJardiance | $601 | $20,59227 claims |
| Astellas Pharma US IncMyrbetriq | $719 | $17,07618 claims |
| Johnson & JohnsonXarelto | $750 | $11,84114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,193 family medicine providers in Maryland.
Other family medicine in Elkton
- Ozden CoksayganElkton$39K
- Edwin Gar-ElElkton$26K
- John MulveyElkton$12K
- Karen DonaldsonBaltimore$899K
- Louis JacquesBaltimore$522K
- Michael ObiefuneBaltimore$291K
- Thomas LawrenceBerlin$254K
- Casey ScottCambridge$88K
- Daljeet SalujaBaltimore$63K
- Sanjay SaxenaHagerstown$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.